This compound is a quinazoline derivative used as a pharmaceutical intermediate in drug synthesis. It features a halogenated aromatic ring system with ether substituents, commonly employed in the manufacturing of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 183322-21-6
3-Bromofuran
pharmaceutical intermediate
5-Amino-2,4,6-trichloropyrimidine
pharmaceutical intermediate
(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid
pharmaceutical intermediate
N-[5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl]-N'-propylsulfamide
pharmaceutical intermediate
(2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate
pharmaceutical intermediate
4,6-diamino-2-chloropyrimidine-5-carbonitrile
pharmaceutical intermediate
2-Amino-5-cyano-3-methylpyridine
pharmaceutical intermediate
5-Bromo-2-iodopyrimidine
pharmaceutical intermediate
4-chloro-6,7-bis(2-chloroethoxy)quinazoline
WXAZLCUYDRYLFC-UHFFFAOYSA-N
C1=C2C(=CC(=C1OCCCl)OCCCl)N=CN=C2Cl